Please login to the form below
economy
This page shows the latest economy news and features for those working in and with pharma, biotech and healthcare.
Malthus’ orphans
Price decline depends on economies of scale, learning curves and competition. ... And if prices don’t decline significantly, rare diseases, personalised therapies and other expensive niche therapies will consume much more than the modest growth
Latest news
-
The NHS at 70th: celebrations, renewed reforms and difficult choices
That notion has been dismissed by most independent experts, who forecast that Brexit will continue to have negative impacts on the economy, which is likely to trump any money saved from ... will not only improve outcomes and make the NHS more efficient,
-
NHS bracing for 'no deal’ Brexit impact, including medicines
Meanwhile, Stevens also pointed out in the interview that the NHS is very reliant on the overall state of the British economy, and of course arguments abound on the impact of
-
Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
Doing so will not only improve the health of our patients, but will promote future collaboration between the life sciences sector and the NHS post-Brexit – benefiting the British economy and
-
Pharma demands guarantees for UK sector deal
A faltering UK economy, with the stormclouds of Brexit on the horizon, means the government’s Treasury department is not able to spend freely, however.
-
Daily Brief: NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal
Uncertainty about the economy, with Brexit as the main source, will make the Treasury even less willing to commit to higher spending.
More from news
Approximately 11 fully matching, plus 538 partially matching documents found.
Latest Intelligence
-
Is flexible working the future?
As the gig economy (a labour market characterised by the prevalence of short-term contracts or freelance work as opposed to permanent jobs) takes hold and the demand for a better ... Flexibility is the way forward. There is a massive desire for it from
-
30 Women Leaders in UK Healthcare
As a recent report from the Commons Science Committee pointed out, Genomics England still has a long way to go to ensure the NHS, its patients and the UK economy benefit
-
Protecting patient privacy
4. Don’t view redaction as the definitive solution. Other than in exceptional cases, defaulting to redaction as a strategy is a false economy.
-
GDPR and the NHS ‘opt out’: a chance to engage patients in research
Increased global investment in clinical trials and real-world evidence studies would feed back directly into the economy and into NHS care.”.
-
The NHS and ABPI at 70: inching closer to the triple win
However there is no question Brexit is making the NHS recruitment crisis worse, as well as currently undermining the economy on which it depends for funding.
More from intelligence
Approximately 4 fully matching, plus 103 partially matching documents found.
Latest appointments
-
Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare
Prior to that his roles included multichannel manager, customer and field support team manager and health economy liaison manager.
-
Clinerion appoints new regional head
He said: “ Clinical trials bring many benefits to a country’s economy, to hospitals, physicians and patients.
-
ABPI Scotland appoints Sandra Auld as director
In addition, Sandra will continue to lead all initiatives to improve the environment for the pharmaceutical industry in Scotland and its role in contributing to the UK economy.”.
-
Life Science Hub Wales names COO
Economy minister for Wales Edwina Hart welcomed Dr Barwick's appointment, saying he will “ play a key role in establishing a thriving ecosystem for the sector in Wales”.
-
Pfizer’s Emms takes up ABPI presidency
opportunity for British patients, the UK economy and industry”.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Think Global
employees) worried that many young adults’ perspectives or educational experiences are not broad enough to operate in a multicultural economy.
-
Is MINT the next BRIC?
Is MINT the next BRIC? In 2001, British economist Jim O’ Neill coined the now ubiquitous acronym ‘ BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, ... With almost 40% of studies conducted by Research Partnership
-
Infographic: ASEAN-6
Infographic: ASEAN-6. Home to over half a billion people, the ASEAN region constitutes the eighth largest economy in the world.
-
Customer Experience in Health Summit
Jo Causon, CEO at the Institute of Customer Service, framed the day with an introduction into the new order of CX; from a transactional to relationship economy, from competition to collaboration.
-
Pharma as change champions
Pharma as change champions. By responding to behaviour change in customers, pharma brands can improve society from local health economies to a global scale.
More from PMHub
Approximately 0 fully matching, plus 61 partially matching documents found.
Featured jobs
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Roche keeps Venclexta train rolling with new leukaemia filing
- NHS England says yes to Roche's Hemlibra
- Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices
- Huntsworth buys Giant Creative Strategy
- Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
- Brexit rebels win vote on European Medicines Agency alignment
- Data Visualisation
- The True Potential of Mobile Health Tech
- NHS England to Vertex: come clean on Orkambi offer
PMHub
CAN advertising
Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
